Skip to Content

BMS 011 (Daklinza 90 mg)

Generic Name: daclatasvir

Pill with imprint BMS 011 is Green, Round and has been identified as Daklinza 90 mg. It is supplied by Bristol-Myers Squibb.

Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 90 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 011

Daklinza 90 mg BMS 011

Daklinza

Generic Name
daclatasvir
Imprint
BMS 011
Strength
90 mg
Color
Green
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
NS5A inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-0011
Inactive Ingredients
lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, silicon dioxide, magnesium stearate, titanium dioxide, polyethylene glycol 400, FD&C Blue No. 2, indigotindisulfonate sodium, aluminum oxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.